Clinical Trial Update: The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating the median effective dose of remimazolam for duodenoscopy insertion during ERCP with alfentanil.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anesthesia

Drugs mentioned

• Alfentanil (alfentanil)
• Remimazolam (remimazolam)

Snippet

Sponsor: Tianjin Nankai Hospital | Conditions: Anesthesia | Phase 4 | Status: UNKNOWN